Cargando…

Strain-specific Plasmodium falciparum growth inhibition among Malian children immunized with a blood-stage malaria vaccine

The blood-stage malaria vaccine FMP2.1/AS02A, comprised of recombinant Plasmodium falciparum apical membrane antigen 1 (AMA1) and the adjuvant system AS02A, had strain-specific efficacy against clinical malaria caused by P. falciparum with the vaccine strain 3D7 AMA1 sequence. To evaluate a potentia...

Descripción completa

Detalles Bibliográficos
Autores principales:	Laurens, Matthew B., Kouriba, Bourema, Bergmann-Leitner, Elke, Angov, Evelina, Coulibaly, Drissa, Diarra, Issa, Daou, Modibo, Niangaly, Amadou, Blackwelder, William C., Wu, Yukun, Cohen, Joe, Ballou, W. Ripley, Vekemans, Johan, Lanar, David E., Dutta, Sheetij, Diggs, Carter, Soisson, Lorraine, Heppner, D. Gray, Doumbo, Ogobara K., Plowe, Christopher V., Thera, Mahamadou A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5345808/ https://www.ncbi.nlm.nih.gov/pubmed/28282396 http://dx.doi.org/10.1371/journal.pone.0173294

Ejemplares similares

Extended Safety, Immunogenicity and Efficacy of a Blood-Stage Malaria Vaccine in Malian Children: 24-Month Follow-Up of a Randomized, Double-Blinded Phase 2 Trial
por: Laurens, Matthew B., et al.
Publicado: (2013)

Safety and Immunogenicity of an AMA1 Malaria Vaccine in Malian Children: Results of a Phase 1 Randomized Controlled Trial
por: Thera, Mahamadou A., et al.
Publicado: (2010)

Immunoglobulin G subclass and antibody avidity responses in Malian children immunized with Plasmodium falciparum apical membrane antigen 1 vaccine candidate FMP2.1/AS02(A)
por: Berry, Andrea A., et al.
Publicado: (2019)

Malaria severity: Possible influence of the E670G PCSK9 polymorphism: A preliminary case-control study in Malian children
por: Arama, Charles, et al.
Publicado: (2018)

Safety and Immunogenicity of an AMA-1 Malaria Vaccine in Malian Adults: Results of a Phase 1 Randomized Controlled Trial
por: Thera, Mahamadou A., et al.
Publicado: (2008)

Safety and Allele-Specific Immunogenicity of a Malaria Vaccine in Malian Adults: Results of a Phase I Randomized Trial
por: Thera, Mahamadou A, et al.
Publicado: (2006)

Malian adults maintain serologic responses to virulent PfEMP1s amid seasonal patterns of fluctuation
por: Ventimiglia, Noah T., et al.
Publicado: (2021)

Protection of Malian children from clinical malaria is associated with recognition of multiple antigens
por: Daou, Modibo, et al.
Publicado: (2015)

Malian children infected with Plasmodium ovale and Plasmodium falciparum display very similar gene expression profiles
por: Tebben, Kieran, et al.
Publicado: (2023)

Stable malaria incidence despite scaling up control strategies in a malaria vaccine-testing site in Mali
por: Coulibaly, Drissa, et al.
Publicado: (2014)

Spatio-temporal analysis of malaria within a transmission season in Bandiagara, Mali
por: Coulibaly, Drissa, et al.
Publicado: (2013)

Spatio-Temporal Dynamics of Asymptomatic Malaria: Bridging the Gap Between Annual Malaria Resurgences in a Sahelian Environment
por: Coulibaly, Drissa, et al.
Publicado: (2017)

Hemoglobin C Trait Provides Protection From Clinical Falciparum Malaria in Malian Children
por: Travassos, Mark A., et al.
Publicado: (2015)

Reduced T Regulatory Cell Response during Acute Plasmodium falciparum Infection in Malian Children Co-Infected with Schistosoma haematobium
por: Lyke, Kirsten E., et al.
Publicado: (2012)

Differential Recognition of Terminal Extracellular Plasmodium falciparum VAR2CSA Domains by Sera from Multigravid, Malaria-Exposed Malian Women
por: Travassos, Mark A., et al.
Publicado: (2015)

Antigen-Specific B Memory Cell Responses to Plasmodium falciparum Malaria Antigens and Schistosoma haematobium Antigens in Co-Infected Malian Children
por: Lyke, Kirsten E., et al.
Publicado: (2012)

Candidate Polymorphisms and Severe Malaria in a Malian Population
por: Toure, Ousmane, et al.
Publicado: (2012)

Phase 1 randomized controlled trial to evaluate the safety and immunogenicity of recombinant Pichia pastoris-expressed Plasmodium falciparum apical membrane antigen 1 (PfAMA1-FVO [25-545]) in healthy Malian adults in Bandiagara
por: Thera, Mahamadou A., et al.
Publicado: (2016)

First characterization of methanogens in oral cavity in Malian patients with oral cavity pathologies
por: Sogodogo, Elisabeth, et al.
Publicado: (2019)

New var reconstruction algorithm exposes high var sequence diversity in a single geographic location in Mali
por: Dara, Antoine, et al.
Publicado: (2017)

Gene expression analyses reveal differences in children’s response to malaria according to their age
por: Tebben, Kieran, et al.
Publicado: (2023)

Blastocystis Colonization Is Associated with Increased Diversity and Altered Gut Bacterial Communities in Healthy Malian Children
por: Kodio, Aly, et al.
Publicado: (2019)

Host and Parasite Transcriptomic Changes upon Successive Plasmodium falciparum Infections in Early Childhood
por: Bradwell, Katie R., et al.
Publicado: (2020)

A high-throughput method for quantifying alleles and haplotypes of the malaria vaccine candidate Plasmodium falciparum merozoite surface protein-1 19 kDa
por: Takala, Shannon L, et al.
Publicado: (2006)

Association of the rs562556 PCSK9 Gene Polymorphism with Reduced Mortality in Severe Malaria among Malian Children
por: Fedoryak, Olesya, et al.
Publicado: (2020)

Long-term Maintenance of CD4 T Cell Memory Responses to Malaria Antigens in Malian Children Coinfected with Schistosoma haematobium
por: Lyke, Kirsten E., et al.
Publicado: (2018)

Successful Profiling of Plasmodium falciparum var Gene Expression in Clinical Samples via a Custom Capture Array
por: Stucke, Emily M., et al.
Publicado: (2021)

Gene expression analyses reveal differences in children’s response to malaria according to their age
por: Tebben, Kieran, et al.
Publicado: (2023)

Immunogenomic profile at baseline predicts host susceptibility to clinical malaria
por: Mbambo, Gillian, et al.
Publicado: (2023)

Variation in the Circumsporozoite Protein of Plasmodium falciparum: Vaccine Development Implications
por: Gandhi, Kavita, et al.
Publicado: (2014)

Correction: Variation in the Circumsporozoite Protein of Plasmodium falciparum: Vaccine Development Implications
por: Gandhi, Kavita, et al.
Publicado: (2016)

Microarray analyses reveal strain-specific antibody responses to Plasmodium falciparum apical membrane antigen 1 variants following natural infection and vaccination
por: Bailey, Jason A., et al.
Publicado: (2020)

Model-based assessment of Chikungunya and O’nyong-nyong virus circulation in Mali in a serological cross-reactivity context
por: Hozé, Nathanaël, et al.
Publicado: (2021)

Author Correction: Model-based assessment of Chikungunya and O’nyong-nyong virus circulation in Mali in a serological cross-reactivity context
por: Hozé, Nathanaël, et al.
Publicado: (2023)

Acceptability and efficacy of intra-rectal quinine alkaloids as a pre-transfer treatment of non-per os malaria in peripheral health care facilities in Mopti, Mali
por: Thera, Mahamadou A, et al.
Publicado: (2007)

Longitudinal analysis of gamma delta T cell subsets during malaria infections in Malian adults
por: Diallo, Hama, et al.
Publicado: (2019)

272 Differential expression of two Plasmodium falciparum variant surface antigen families in Malian children with cerebral malaria compared to mild malaria
por: Lawton, Jonathan G., et al.
Publicado: (2023)

Factors associated with coverage of praziquantel for schistosomiasis control in the community-direct intervention (CDI) approach in Mali (West Africa)
por: Dabo, Abdoulaye, et al.
Publicado: (2013)

Descriptive study of cases of schizophrenia in the Malian population
por: Coulibaly, Souleymane dit Papa, et al.
Publicado: (2021)

Impact of Three-Year Intermittent Preventive Treatment Using Artemisinin-Based Combination Therapies on Malaria Morbidity in Malian Schoolchildren
por: Maiga, Hamma, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_0dr82hv17snh8r9d4tls9o0fg7